Neuron Pathology & Diagnostics Private Limited

Neuron Pathology & Diagnostics Private Limited - healthcare in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U85191MH2011PTC224598 Incorporated 02 December 2011 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹2.29 Cr
▼ 4% YoY
Net profit · FY 2025
₹14.72 Lakh
Net margin 6.4%
EBITDA · FY 2025
₹26.65 Lakh
EBITDA margin 11.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹25 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings

About Neuron Pathology & Diagnostics Private Limited

Data last updated:

Neuron Pathology & Diagnostics Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 02 December 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85191MH2011PTC224598.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gopal Deenanath Singh and Vivek Virendra Goyal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D Wing 702 Bldg Rosewood Prestige Residency G B Rd, Thane, Maharashtra, India – 400607.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.29 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹14.72 Lakh (net margin 6.4%) and EBITDA of ₹26.65 Lakh (EBITDA margin 11.7%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 11% over five years.

As per MCA filings, the company has open charges of ₹25 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Neuron Pathology & Diagnostics Private Limited
CIN U85191MH2011PTC224598
Registration Number 224598
Incorporation Date 02 December 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    D Wing 702 Bldg Rosewood Prestige Residency G B Rd, Thane, Maharashtra, India – 400607
  • Industry
    Healthcare, Preventive Health Services
Comprehensive company report
Neuron Pathology & Diagnostics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Neuron Pathology & Diagnostics Private Limited report

Financials, compliance, directors, charges, ownership and filings for Neuron Pathology & Diagnostics Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Neuron Pathology & Diagnostics Private Limited

The main business activity of Neuron Pathology & Diagnostics is human health and social work activities. In detail, this covers human health activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
QHuman health and social work activities86Human health activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Neuron Pathology & Diagnostics Private Limited FY 2025 filings available

Neuron Pathology & Diagnostics Private Limited reported revenue of ₹2.29 Cr (down 4% YoY) for FY 2025.

Revenue · FY 2025
₹2.29 Cr ▼ 4%
Net profit · FY 2025
₹14.72 Lakh margin 6.4%
EBITDA · FY 2025
₹26.65 Lakh margin 11.7%

Compounded Annual Growth Rate (CAGR) of Neuron Pathology & Diagnostics Private Limited

Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 4%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 1%
5 years · compounded
▲ 6%

Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Neuron Pathology & Diagnostics Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹26.65 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹14.72 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Neuron Pathology & Diagnostics Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin11.7%••••••••••••••••
Net Profit Margin6.4%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Neuron Pathology & Diagnostics are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Neuron Pathology & Diagnostics Private Limited

Neuron Pathology & Diagnostics Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Muktimission Sewa Hospital Private Limited₹2.29 Cr (FY 2025)••••••••-20.0%••••Varanasi, Uttar Pradesh, India
Varroc Lifesciences Private Limited₹2.29 Cr (FY 2025)••••••••-1.0%••••Nagpur, Maharashtra, India
Techmeds Health Solutions Private Limited₹2.29 Cr (FY 2025)••••••••-29.0%••••Pune, Maharashtra, India
Sathya Superspeciality Health Village Private Limited₹2.29 Cr (FY 2022)••••••••42.0%••••Coimbatore, Tamil Nadu, India
Anivet Health Care Private Limited₹2.29 Cr (FY 2021)••••••••16.0%••••Bharatpur, Rajasthan, India
Neuron Pathology & Diagnostics Private Limited this company₹2.29 Cr (FY 2025)••••••••-4.0%••••Thane, Maharashtra, India
Arohana Support Private Limited₹2.28 Cr (FY 2025)••••••••-39.0%••••Bangalore, Karnataka, India
Babla Holistic Wellness Private Limited₹2.28 Cr (FY 2024)••••••••216.0%••••Delhi, India
JSV Innovations Private Limited₹2.28 Cr (FY 2025)••••••••-19.0%••••Kolkata, West Bengal, India
Anfa Holistic Tourism Private Limited₹2.28 Cr (FY 2025)••••••••-14.0%••••Delhi, India
Ru Multispeciality Healthcare Private Limited₹2.28 Cr (FY 2025)••••••••17.0%••••Rewari, Haryana, India

Peers are the five companies nearest above and the five nearest below Neuron Pathology & Diagnostics by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Neuron Pathology & Diagnostics Private Limited

Neuron Pathology & Diagnostics Private Limited is audited by G.D. BHATI & ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
G.D. BHATI & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Neuron Pathology & Diagnostics Private Limited

Neuron Pathology & Diagnostics has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Gopal Deenanath SinghDirector02 Dec 201114 Years 10 MonthsCurrent
Vivek Virendra GoyalDirector02 Dec 201114 Years 10 MonthsCurrent

Ownership and Shareholding of Neuron Pathology & Diagnostics Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Neuron Pathology & Diagnostics Private Limited

Open charges
₹25 Lakh
Satisfied charges
None
Breakdown by lending institutions
Corporation Bank Thane Ghodbunder Branch₹0.25 Cr
Latest charge details
DateLenderAmountStatus
13 Feb 2015Corporation Bank Thane Ghodbunder Branch₹25 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Neuron Pathology & Diagnostics Private Limited

Employment history and EPFO contributions of people linked to Neuron Pathology & Diagnostics.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Neuron Pathology & Diagnostics Private Limited

Neuron Pathology & Diagnostics Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Gopal Deenanath Singh was appointed as Director on 02 Dec 2011.

AGM
Neuron Pathology & Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Neuron Pathology & Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Corporation Bank Thane Ghodbunder Branch amounted to Rs. 25.00 Lakh with Charge ID 10553650 was registered on 13 Feb 2015.
Appointed
Gopal Deenanath Singh was appointed as Director.
Appointed
Vivek Virendra Goyal was appointed as Director.
Incorporation
02 Dec 2011
Neuron Pathology & Diagnostics Private Limited was registered on 02 Dec 2011 with Roc Mumbai & aged 14 years 10 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Neuron Pathology & Diagnostics Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Neuron Pathology & Diagnostics Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Neuron Pathology & Diagnostics Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Neuron Pathology & Diagnostics Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Neuron Pathology & Diagnostics Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neuron Pathology & Diagnostics Private Limited

Neuron Pathology & Diagnostics is an active private limited company based in Thane, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 02 December 2011 (15+ years old) and is registered under CIN U85191MH2011PTC224598.

Neuron Pathology & Diagnostics reported revenue of ₹2.29 Cr for FY 2025 (down 4% YoY).

Neuron Pathology & Diagnostics has 2 current directors:

Neuron Pathology & Diagnostics reported a net profit of ₹14.72 Lakh (net margin 6.4%) and EBITDA of ₹26.65 Lakh (EBITDA margin 11.7%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Neuron Pathology & Diagnostics is 4% over three years and 11% over five years. In the latest year (FY 2025) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.

The CIN (Corporate Identification Number) of Neuron Pathology & Diagnostics is U85191MH2011PTC224598. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Neuron Pathology & Diagnostics was incorporated on 02 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Neuron Pathology & Diagnostics by revenue are Muktimission Sewa Hospital Private Limited, Varroc Lifesciences Private Limited, Techmeds Health Solutions Private Limited, Sathya Superspeciality Health Village Private Limited, Anivet Health Care Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Services).

Gopal Deenanath Singh was appointed as Director on 02 Dec 2011. Vivek Virendra Goyal was appointed as Director on 02 Dec 2011.

The registered office of Neuron Pathology & Diagnostics is at D Wing 702 Bldg Rosewood Prestige Residency G B Rd, Thane, Maharashtra, India – 400607.

Neuron Pathology & Diagnostics has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available